Posted by Kevin Doe
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external Read More...
Posted by Michael Doe
To order this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html Key Inclusions A detailed assessment of the current market landscap Read More...
Posted by Michael Doe
Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract ser Read More...
Posted by Michael Doe
Report link - https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html\ Key Inclusions A review of the current market landscape of companies offering ph Read More...
Posted by Michael Doe
To order this 170+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html Key Inclusions A detailed review of the overall landscape of frag Read More...
Posted by Michael Doe
To order this 250+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html Key Inclusions A detailed review of the overall landscape Read More...
Posted by Michael Doe
Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content &n Read More...
Posted by Flexotone Joint
Flexotone A rabbet joint could be very commonly utilized in Flexotone drawers shelves and other carpentry packages. To shape this joint a rabbet or a steplike groove is carved along the whole edge of one workpi Read More...
Posted by Damon Salvatore
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufact Read More...
Posted by Damon Salvatore
An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer lif Read More...
Posted by Damon Salvatore
Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient Read More...
Posted by sophia ks
Does Dentitox Pro Really Work – An Honest Review It would be fair to say that Dentitox Pro has ingredients that have been shown and proven to be great for oral and dental health. However, does it have the support Read More...
Posted by Steffan Joe
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche Read More...
Posted by Steffan Joe
With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry Read More...
Posted by Steffan Joe
Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment t Read More...
Posted by Kevin Doe
Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development Read More...
Posted by Kevin Doe
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-bil Read More...
Posted by Kevin Doe
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator comp Read More...
Posted by Seeshshy Seeshshy
Right now, others are looking for workouts which help these products generate a pile of cash successfully. Getting earnings isn’t challenging for people who had assistance from various programs from the internet, Read More...
Posted by Visbody Visbody
The increasing trend of obesity and being overweight is leading to the development of a number of metabolic disorders and chronic conditions in a new generation all over the world. It is leading to a ri Read More...
Posted by Mason Joe
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages &n Read More...
Posted by Mason Joe
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty Read More...
Posted by Damon Salvatore
To order this detailed 485+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape, providing information on drug developer(s) (year of establishment, headqua Read More...
Posted by Damon Salvatore
Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the u Read More...
Posted by Damon Salvatore
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche Read More...